OTCMKTS:MDIT Medite Cancer Diagnostics (MDIT) Stock Price, News & Analysis → Reclusive millionaire’s final warning about America (From Weiss Ratings) (Ad) Free MDIT Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get Medite Cancer Diagnostics alerts: Email Address Ad Weiss Ratings[Urgent] Protect your money before NovemberDo you feel like something strange is happening in America? Every day, hundreds of thousands of military-aged men are pouring through our broken borders … I share all the details about what's happening, and give you the three steps I feel you must take to prepare yourself — RIGHT NOW.Click here to watch now. About Medite Cancer Diagnostics Stock (OTCMKTS:MDIT)Medite Cancer Diagnostics, Inc. operates as a medical technology company. It develops, manufactures, and markets molecular biomarkers, medical devices, and consumables for the detection, risk assessment, and diagnosis of cancerous and precancerous conditions and related diseases. The company offers USE 33, an ultrasonic decalcification instrument that automatically runs the process under controlled temperatures; TPC 15 Duo and Trio, a tissue processing instrument; TES 99 and TES Valida cooling units; and M530, A550, M380 microtomes for tissue sectioning. It also provides M630, a freezing microtome; TST44, a robotic multi-staining system; COT 20, a linear staining system; and RCM 9000, ACS 720, and TWISTER robotic coverslippers. In addition, the company develops SoftKit device for the self-collection of a sample that can be evaluated to provide an assessment of the health of the entire female genital tract. It sells its products through direct sales and distributors in the United States, China, Europe, and North Africa. The company serves histology and cytology laboratories associated with hospitals or research institutions, and independent laboratories. Medite Cancer Diagnostics, Inc. is based in Orlando, Florida.Read More Ad Weiss Ratings[Urgent] Protect your money before NovemberDo you feel like something strange is happening in America? Every day, hundreds of thousands of military-aged men are pouring through our broken borders … I share all the details about what's happening, and give you the three steps I feel you must take to prepare yourself — RIGHT NOW.Click here to watch now. MDIT Stock News HeadlinesSeptember 26, 2023 | finance.yahoo.comCleveland Diagnostics Announces Prostate Cancer Awareness Month Campaign: ‘A PSA on PSA’September 2, 2023 | finance.yahoo.comPancreatic Cancer Diagnostics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028June 18, 2024 | Weiss Ratings (Ad)[Urgent] Protect your money before NovemberDo you feel like something strange is happening in America? Every day, hundreds of thousands of military-aged men are pouring through our broken borders … I share all the details about what's happening, and give you the three steps I feel you must take to prepare yourself — RIGHT NOW.August 23, 2023 | finance.yahoo.comBreast Cancer Diagnostics Market to Grow Rapidly at a CAGR of 8.7% by 2030 | DataM IntelligenceAugust 18, 2023 | yahoo.comHere's why some people keep their cancer diagnosis to themselves: 'An incredibly personal decision'May 10, 2023 | msn.comA New Urine Test Could Be a Simple Way to Check For CancerApril 11, 2023 | msn.comPromising new AI can detect early signs of lung cancer that doctors can't seeMarch 17, 2023 | benzinga.comLiver Cancer Diagnostics Market Value to Experience over 2x Growth; Liver Function Tests (LFTs) Key Approach to Detect Malignancy: Fact.MRJune 18, 2024 | Weiss Ratings (Ad)[Urgent] Protect your money before NovemberDo you feel like something strange is happening in America? Every day, hundreds of thousands of military-aged men are pouring through our broken borders … I share all the details about what's happening, and give you the three steps I feel you must take to prepare yourself — RIGHT NOW.March 11, 2023 | finance.yahoo.comCancer Diagnostics Global Market Report 2023February 23, 2023 | yahoo.comCancer Diagnostics Market Size Will Reach USD 332.4 Billion by 2032 - Market.usFebruary 21, 2023 | marketwatch.comForecasting the Future of Noninvasive Cancer Diagnostics Market 2023: Regional Trends and Industry DevelopmentsFebruary 19, 2023 | marketwatch.comNoninvasive Cancer Diagnostics Technology Market: Exploration of the Top Regions and Players with OpportunitiesFebruary 18, 2023 | finance.yahoo.comCervical Cancer Diagnostics Global Market Report 2023February 18, 2023 | marketwatch.comProstate Cancer Diagnostics Market 2023: Emerging Trends and Best Practices in Futurism till 2028January 19, 2023 | finance.yahoo.comGlobal Prostate Cancer Diagnostics Market to Reach $8.8 Billion by 2027January 16, 2023 | forbes.comMIT & Mass General Hospital Have Developed An AI System That Can Detect Lung CancerJanuary 11, 2023 | benzinga.comBreast Cancer Diagnostics Global Market Report 2023: Industry to Reach $6.16 Billion by 2027 at a 6.67% CAGRJanuary 11, 2023 | finance.yahoo.comCancer Diagnostic Market will reach to USD 276.62 billion by 2029 : GreyViewsOctober 4, 2022 | mirror.co.ukSisters receive shock cancer diagnosis within just six weeks of each otherSeptember 20, 2022 | reuters.comMedite Cancer Diagnostics IncJuly 29, 2021 | barrons.comMedite Cancer Diagnostics Inc.See More Headlines Receive MDIT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medite Cancer Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:MDIT CUSIPN/A CIK75439 Webwww.medite-group.com Phone(407) 996-9630Fax407-996-9631Employees69Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Jeffrey Rencher (Age 57)Chief Marketing & Business Development Officer Comp: $95.6kKey CompetitorsAdynxxOTCMKTS:ADYXCalmare TherapeuticsOTCMKTS:CTTCDex LiquidatingOTCMKTS:DXTRQEndologixOTCMKTS:ELGXQHypertension DiagnosticsOTCMKTS:HDIIView All Competitors MDIT Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Medite Cancer Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medite Cancer Diagnostics investors own include Cracker Barrel Old Country Store (CBRL), Banyan Gold (BYN), Blackstone Mortgage Trust (BXMT), Invesco BulletShares 2020 Corporate Bond ETF (BSCK), Bank of Marin Bancorp (BMRC), BlackRock (BLK), Avon Products (AVP), Grupo Aeroportuario del Sureste, S. A. B. de C. V. (ASR), Armada Hoffler Properties (AHH) and Atlantic Gold (AGB). How do I buy shares of Medite Cancer Diagnostics? Shares of MDIT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MDIT) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | Sponsoredwhy 99.94% won’t make you moneyI believe there's only 5-7 stocks that you should trade in 2024. But here's the catch…because there's alway...Prosper Trading Academy | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medite Cancer Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medite Cancer Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
